Clinical Trial: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06997367) titled 'Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)' on May 14.

Brief Summary: Phase II trial to establish the safety, reactogenicity, and immunogenicity of the MTBVAC with a licensed BCG vaccine as a comparator in both TB naive (QFT PLUS negative) and TB exposed (QFT PLUS positive) healthy adults and adolescents.

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Tuberculosis (TB)

Intervention: BIOLOGICAL: MTBVAC

MTBVAC (BBV169) vaccine is a freeze-dried powder containing live attenuated Mycobacterium tuberculosis (M. tb), which is prese...